About this episode
PhaseWell Research, a clinical trial company, expands its Northeast presence by acquiring Chase Medical Research. Chase, with over two decades of experience in various health areas, will contribute its expertise in cardiometabolic and central nervous system trials. The partnership aims to bring more advanced trials to Connecticut patients and broaden Chases reach, enhancing options in key health areas nationwide.
Support the show:Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai.
View sources & latest updates:https://sources.thednn.ai/034d592560d56882
